# The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-22 21:29 UTC · Category: Business · Sources: 4 · Current Velocity: 2.5

## Executive Summary
4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

## Intelligence Brief
"The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High" is generating significant coverage in the Business category, with 4 articles from 4 distinct sources tracked by Newsylist so far.


Outlets currently covering the story include FirstWord Pharma, Yahoo Finance, WSJ and Pluang. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### Why is "The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High" trending?
Because 4 independent news sources published 4 articles about it in a short window — a coverage burst Newsylist classifies as a trend.

### How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.

### Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.

## Key People, Organizations & Locations
Phase, Arrowhead, Ionis, Redemplo, Best-Case Scenario That Shot Arrowhead Stock Sky-High, Arrowhead Pharmaceuticals, Arrowhead Shares Soar, Strong Triglyceride Drug Data

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Yahoo Finance | Arrowhead Pharmaceuticals (ARWR) Stock Looks Fairly Priced With Strong Sales But A Demanding 398% Run | 2026-07-22 20:05 | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxOUGpBR01ZMWsyM21WSThKOWdlRE55cnZ2ZjBhX0l2TENnRk5za2k3VzJSQl92Y2xXZXp5cHN4Nm1RcHppRllXWXVYSGJoNXdjZUZhS3RCVGZ1OEVoSFRVbzhrV0N3N2xPOWJ6NW9DX0ZKbWlMTm1lSzh0SnZ2RzBHR1ZfcG5GWVEydVZNQjBHbDZsVTBRdXNGWHB2LWpuU0Fva20wblk1eFd4Qjg?oc=5) |
| FirstWord Pharma | Arrowhead looses late-stage Redemplo data in sHTG, setting up head-to-head with Ionis | 2026-07-22 20:05 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFByOEJBRXFLeGNlT2hUbFRwT3gyczM4VXZjQ2E0T1BlX3FDSVRGanVxQ3daNEpsZVpZbk1VU2ZjQURNMUpaN3dMcXNqSzBHcUtXUy1r?oc=5) |
| Yahoo Finance | Arrowhead Pharmaceuticals shares surge after positive Phase 3 results for plozasiran (NASDAQ:ARWR) | 2026-07-22 20:05 | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxQc01mNkZHUjdDWDR6N3R1MzRYRUhBNmJDdmdrYUdTVDhqTm1UQ3NYVkJfNXJCejNSWGlaOUVOWmVOcW5OdGQta0JnZDlNdE9qTjFaeWpnci1vakNJTks2MVI5RmhPbkFzcERxcmtkY1BTRUYxWF9QbHlEb3FoQTZXRGFBeHViZEh1T3RIQkx3eHZiYWlxMmdyNlhiVWJscmNUS0RXSTNpRDFwQmxq?oc=5) |
| WSJ | Arrowhead Shares Soar on Strong Triglyceride Drug Data | 2026-07-22 20:05 | [Source Link](https://news.google.com/rss/articles/CBMi8wFBVV95cUxNWU50T2JCeXBlVTJoaHZrSVdmQUdwOERhU3VnOG5lTm9wVjRsME0zLXpQWi0zeEhZWkdPcGNWYXp6TEpsRVdFM0t5YmFJdzVKaExCaERuNWZnZ3I1dW5PQ1g5OGZtc3FZQS1DMkIxRW5USzROTmdoQjBQU1RNOWxFd0RpWUxmc19rdkk3dVVOV2JqNEJOdUN3dm9YYzA0a2haNklIMTdyYUFXX2szNzQ1Um5xbzFDam1VV01Fa1NxRUlKcnMwdzRlYk93ZFFJOEg3TzRKYmEtVnVNLS1JM0RERldUOF8yN0gxMjg5RVlkNWl2Yms?oc=5) |
| Pluang | Arrowhead Pharma's stock jumps after strong tri... | 2026-07-22 20:05 | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxOZnlCVTdrZmUtdk9ubDFZV1kzZ0FuOVllUHhiLWxaYVlGNkVORTVvV0F4UzNJTkRjSnpVZnJ5UzJ3MlVmNDNhTXNGNERlRzVQM0d3UW5fb2VXR0RsWWowTU5lcklERkx4a1hlNkhLdkNFUW51aHh6bjBoaWRBUVl0dGhiSmZwQWpVaEpTRWQ4Y3lNM1p6SkFOdmxPVFh0cHpXWmZUdU1B?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-22/the-best-case-scenario-that-shot-arrowhead-stock-sky-high*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*